Trans Genic INC. japanese
Corporate Information
News Releases
Products & Service
Investor Relations
Career
What's New
2009

Nov.24 products Product Launch (3 antibodies, 1 kit)
Nov.04 products Product Launch (2 antibodies)
Oct.16 products Product Launch (99 antibodies)
Oct.09 products Product Launch (12 antibodies)
Sep.18 products Launch of Anti Human COPZ1 Monoclonal Antibody
Sep.11 products Product Launch (Glucose-derived AGEs ELISA Kit)
Sep.11 products Launch of AGEs Assay Kit
Aug.31 products Product Launch (3 antibodies)
Aug.31 products Launch of Anti GPCR Monoclonal Antibodies
Jul.27 products Notice of Conclusion of Joint Research and Development Agreement with International Medical Center of Japan
Jul.22 products Product Launch (6 antibodies)
Jul.22 products Launch of Anti GPCR Monoclonal Antibodies
Jun.26 products Notice of Revised Consolidated Earnings Forecast
Jun.26 products Kajitsudo is Included in the Scope of Consolidation
Jun.24 products Product Launch (3 antibodies)
Jun.24 products Launch of Anti GPCR Monoclonal Antibodies
Jun.19 products TRANS GENIC Granted Japanese Patent for Antibody against Pancreatic Cancer Marker and its Diagnostic Application
May.27 products Product Launch (8 antibodies)
May.15 press release Notice of Change of Directors
May.15 press release Notice of Partial Amendment to Articles of Incorporation
May.15 products We renewed a list of gene knockout mice (346 lines updated).
Apr.24 products Product Launch (2 antibodies)
Apr.23 press release Notice of Resignation of Director
Apr.20 press release Notice of Capital and Business Tie-up with Kajitsudo
Apr.20 press release TRANS GENIC Licenses Knockout Mouse to Takeda Pharmaceutical Company
Apr.10 press release “GANP® Mouse Technology” has been Patented by European Patent Office
Apr.09 press release Notice of Conclusion of Marketing Agreement with Transposagen Biopharmaceuticals, Inc.
Apr.02 press release Notice of Change of CEO
Mar.13 products Product Launch (56 antibodies)
Feb.26 press release "GANP® Mouse Technology” has been Patented by Australian Patent Office
Feb.9 press release Patent Application for Antibody against Bile Duct Cancer Marker and its Diagnostic Application
Jan.23 products Product Launch (1 antibody)
Jan.22 press release TRANS GENIC’s Subject was Selected for “Science and Technology Incubation Program in Advanced Regions” by Japan Science and Technology Agency
Jan.19 press release Notice of Conclusion of Joint Research Agreement with National Cancer Center
 
 
>>2010
>>2009
>>2008
>>2007
>>2006
>>
2005
>>
2004
Contact UsTerms of UseSite MapWhat's New